| In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices SA Bravo, MC Lamas, CJ Salomón J Pharm Pharm Sci 5 (3), 213-219, 2002 | 307 | 2002 |
| Recent developments in chemical deprotection of ester functional groups CJ Salomon, EG Mata, OA Mascaretti Tetrahedron 49 (18), 3691-3734, 1993 | 111 | 1993 |
| First century of chagas' disease: An overview on novel approaches to nifurtimox and benznidazole delivery systems CJ Salomon Journal of Pharmaceutical Sciences 101 (3), 888-894, 2012 | 102 | 2012 |
| Development of prednisone: polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters D Leonardi, MG Barrera, MC Lamas, CJ Salomón AAPS PharmSciTech 8, 221-228, 2007 | 102 | 2007 |
| Swellable matrices for the controlled‐release of diclofenac sodium: Formulation and in vitro studies SA Bravo, MC Lamas, CJ Salomon Pharmaceutical development and technology 9 (1), 75-83, 2004 | 93 | 2004 |
| Scope and mechanism of deprotection of carboxylic esters by bis (tributyltin) oxide CJ Salomon, EG Mata, OA Mascaretti The Journal of Organic Chemistry 59 (24), 7259-7266, 1994 | 91 | 1994 |
| Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy M Moreno-Sastre, M Pastor, CJ Salomon, A Esquisabel, JL Pedraz Journal of Antimicrobial Chemotherapy 70 (11), 2945-2955, 2015 | 90 | 2015 |
| Development of novel formulations for Chagas’ disease: optimization of benznidazole chitosan microparticles based on artificial neural networks D Leonardi, CJ Salomón, MC Lamas, AC Olivieri International journal of pharmaceutics 367 (1-2), 140-147, 2009 | 90 | 2009 |
| Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole MC Lamas, L Villaggi, I Nocito, G Bassani, D Leonardi, F Pascutti, E Serra, ... International journal of pharmaceutics 307 (2), 239-243, 2006 | 81 | 2006 |
| Development and evaluation of buccal films based on chitosan for the potential treatment of oral candidiasis G Tejada, MG Barrera, GN Piccirilli, M Sortino, A Frattini, CJ Salomón, ... Aaps Pharmscitech 18, 936-946, 2017 | 77 | 2017 |
| Efficient and selective dealkylation of phosphonate dilsopropyl esters using Me3SiBr CJ Salomon, E Breuer Tetrahedron letters 36 (37), 6759-6760, 1995 | 64 | 1995 |
| Formulation and in-vitro efficacy of antifungal mucoadhesive polymeric matrices for the delivery of miconazole nitrate G Tejada, GN Piccirilli, M Sortino, CJ Salomón, MC Lamas, D Leonardi Materials Science and Engineering: C 79, 140-150, 2017 | 62 | 2017 |
| Effects of benznidazole: cyclodextrin complexes on the drug bioavailability upon oral administration to rats D Leonardi, ME Bombardiere, CJ Salomon International journal of biological macromolecules 62, 543-548, 2013 | 59 | 2013 |
| In vivo evaluation of albendazole microspheres for the treatment of Toxocara canis larva migrans MG Barrera, D Leonardi, RE Bolmaro, CG Echenique, AC Olivieri, ... European Journal of Pharmaceutics and Biopharmaceutics 75 (3), 451-454, 2010 | 56 | 2010 |
| Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl-and cycloalkylcarbamoylphosphonic acids E Breuer, CJ Salomon, Y Katz, W Chen, S Lu, GV Röschenthaler, ... Journal of medicinal chemistry 47 (11), 2826-2832, 2004 | 54 | 2004 |
| Bis (tributyltin) oxide. A mild, neutral and selective reagent for cleavage of esters. Scope and limitation of the reaction CJ Salomon, EG Mata, OA Mascaretti Tetrahedron letters 32 (34), 4239-4242, 1991 | 53 | 1991 |
| Promising efficacy of benznidazole nanoparticles in acute Trypanosoma cruzi murine model: in-vitro and in-vivo studies ML Scalise, EC Arrúa, MS Rial, MI Esteva, CJ Salomon, LE Fichera The American journal of tropical medicine and hygiene 95 (2), 388, 2016 | 51 | 2016 |
| Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations D Real, S Hoffmann, D Leonardi, C Salomon, FM Goycoolea PLoS One 13 (12), e0207625, 2018 | 47 | 2018 |
| Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review EC Arrúa, KP Seremeta, GR Bedogni, NB Okulik, CJ Salomon Acta tropica 198, 105080, 2019 | 44 | 2019 |
| Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease MS Rial, ML Scalise, EC Arrúa, MI Esteva, CJ Salomon, LE Fichera PLoS neglected tropical diseases 11 (12), e0006119, 2017 | 41 | 2017 |
